A for­mer Gary Glick biotech, now a pen­ny stock, will lay off staff and close of­fices af­ter PhII fail

Pen­ny stock First Wave Bio­Phar­ma is join­ing the lay­off wave fol­low­ing the re­sults of its Phase II tri­al.

The Flori­da-based biotech com­pa­ny, which was …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.